Drug Abuse Testing Market Expanding at a CAGR of 7.2% during 2022-2027
Drug Abuse Testing Market Research Report
SHERIDAN, WYOMING, UNITED STATES, December 5, 2022 /EINPresswire.com/ -- IMARC Group has recently released a new research study titled “Drug Abuse Testing Market: Global Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2022-2027”, offers a detailed analysis of the market drivers, segmentation, growth opportunities, trends, and competitive landscape to understand the current and future market scenarios.
What are the growth prospects of the drug abuse testing industry?
The global drug abuse testing market size reached US$ 6.1 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 9.2 Billion by 2027, exhibiting a growth rate (CAGR) of 7.2% during 2022-2027.
What is a drug abuse testing?
Drug abuse represents the deliberate consumption of illegal substances or overindulgence of prescribed psychoactive and performance-enhancing chemicals and over-the-counter (OTC) medications. It can affect the body as well as the mind and lead to several disorders, including addiction. Consequently, drug abuse is diagnosed among individuals by using numerous testing methods to provide effective treatment for related disorders. In line with this, drug abuse testing aids in managing acute mental status and seizure cases in the emergency room and identifying children and newborns at risk of exposure to illicit drugs. Presently, it finds extensive applications in workplaces before hiring an applicant.
Impact of COVID-19:
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Request and get a sample brochure for free: https://www.imarcgroup.com/drug-abuse-testing-market/requestsample
What are the major market drivers in the drug abuse testing market?
The widespread adoption of cannabinoids, cocaine, lysergic acid diethylamide (LSD), barbiturates, opiates, amphetamines, alcohol, diazepam, and ketamine for their non-therapeutic and medicinal uses, mind-altering characteristics, and other purposes, including weight loss and enhancing athletic performance is primarily driving the drug abuse testing market. Additionally, the growing number of pain management and opioid dependency clinics is further catalyzing the market growth. Besides this, drug abuse can create safety and health hazards and decrease the productivity and morale of an individual, which is propelling the demand for drug abuse testing to provide a safe workplace, screen employees and job applicants, comply with strict rules and regulations by government bodies, etc. Moreover, leading companies are providing automated testing and analysis and offering at-home use kits for instant drug abuse tests, thereby positively influencing the global market. Apart from this, the expanding e-commerce industry is anticipated to fuel the drug abuse testing market over the forecasted period.
Ask Analyst for 10% free customized report: https://www.imarcgroup.com/request?type=report&id=4388&flag=C
Report Segmentation:
The report has segmented the market into the following categories:
Breakup by Product:
Analyzers
Immunoassays Analyzers
Chromatographic Devices
Breath Analyzers
Rapid Testing Devices
Urine Testing Devices
Oral Fluid Testing Devices
Consumables
Laboratory Services
Breakup by Sample:
Urine
Oral Fluid (Saliva)
Hair
Breath
Others
Breakup by End User:
Hospitals
Diagnostic Laboratories
Forensic Laboratories
Workplaces
Others
By Geography:
North America (United States, Canada)
Europe (Germany, France, United Kingdom, Italy, Spain, Others)
Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
Latin America (Brazil, Mexico, Others)
Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)
List of Major Key Players:
Abbott Laboratories
Bio-Rad Laboratories Inc
Danaher Corporation
Drägerwerk AG & Co. KGaA
Hoffmann-La Roche AG
Laboratory Corporation of America Holdings
Omega Laboratories Inc
Quest Diagnostics Incorporated
Siemens AG
Thermo Fisher Scientific Inc
United States Drug Testing Laboratories Inc
Other Report by IMARC Group:
Onychomycosis Treatment Market: https://www.digitaljournal.com/pr/onychomycosis-treatment-market-estimated-to-exceed-us-4-12-billion-globally-by-2027-imarc-group
Magneto Resistive RAM (MRAM) Market: https://www.digitaljournal.com/pr/magneto-resistive-ram-mram-market-estimated-to-reach-us-3436-9-million-globally-by-2027-imarc-group
BFSI Crisis Management Market: https://www.digitaljournal.com/pr/with-18-6-cagr-bfsi-crisis-management-market-size-to-reach-us-31-16-billion-2022-2027
Lateral Flow Assay Market: https://www.digitaljournal.com/pr/with-5-2-cagr-lateral-flow-assay-market-size-worth-us-12-7-billion-in-2027
Mango Butter Market: https://www.digitaljournal.com/pr/at-6-50-cagr-mango-butter-market-to-be-worth-us-135-6-million-by-2027
Latin America Dry Eye Syndrome Market: https://www.digitaljournal.com/pr/latin-america-dry-eye-syndrome-market-2022-2027-share-trends-analysis-demand-and-key-players
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic, and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology, and novel processing methods are at the top of the company’s expertise.
Elena Anderson
IMARC Services Private Limited
+1 6317911145
email us here
EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.
